Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer

BACKGROUND: Despite advances in treatment, recurrence and mortality rates from breast cancer (BrCa) continue to rise, clinical effectiveness is limited, and prognosis remains disappointing, especially for patients with HER2-positive, triple-negative, or advanced breast cancer. Based on cuproptosis-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chun, Zhang, Yicong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329336/
https://www.ncbi.nlm.nih.gov/pubmed/37422644
http://dx.doi.org/10.1186/s12920-023-01590-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329336/
https://www.ncbi.nlm.nih.gov/pubmed/37422644
http://dx.doi.org/10.1186/s12920-023-01590-z

Ejemplares similares